Biomark Diagnostics Inc. (BUX:CSE) closed at $0.420 on November 12, 2026, unchanged on the day. The stock trades 34.4% below its 52-week high of $0.640 and 23.5% above its 52-week low of $0.340. Over the past year, it gained 23.5%. Biomark Diagnostics Inc. is part of the Life Sciences sector.
In 252 trading sessions since November 13, 2025, BUX closed higher on 56 days (22%). Its best day was December 1, 2025 (+17.50%) and its worst was August 20, 2026 (-13.79%). The stock moved 10% or more in a single session 8 times. It opened at least 5% above the previous day's high 2 times.
Biomark Diagnostics Inc is an oncology focused company. The Company is engaged in developing commercialization avenues for cancer detection and monitoring business.
Find more stocks like BUX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.